The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.
复制标题
DOI:
10.1016/s2213-2600(21)00286-1
复制
发表时间:
2021-12
期刊:
影响因子:
--
通讯作者:
International COVID-19 Airways Diseases Group
中科院分区:
文献类型:
--
作者:
Adeloye D;Elneima O;Daines L;Poinasamy K;Quint JK;Walker S;Brightling CE;Siddiqui S;Hurst JR;Chalmers JD;Pfeffer PE;Novotny P;Drake TM;Heaney LG;Rudan I;Sheikh A;De Soyza A;International COVID-19 Airways Diseases Group
Persistent ill health after acute COVID-19—referred to as long COVID, the post-acute COVID-19 syndrome, or the post-COVID-19 condition—has emerged as a major concern. We undertook an international consensus exercise to identify research priorities with the aim of understanding the long-term effects of acute COVID-19, with a focus on people with pre-existing airways disease and the occurrence of new-onset airways disease and associated symptoms. 202 international experts were invited to submit a minimum of three research ideas. After a two-phase internal review process, a final list of 98 research topics was scored by 48 experts. Patients with pre-existing or post-COVID-19 airways disease contributed to the exercise by weighting selected criteria. The highest-ranked research idea focused on investigation of the relationship between prognostic scores at hospital admission and morbidity at 3 months and 12 months after hospital discharge in patients with and without pre-existing airways disease. High priority was also assigned to comparisons of the prevalence and severity of post-COVID-19 fatigue, sarcopenia, anxiety, depression, and risk of future cardiovascular complications in patients with and without pre-existing airways disease. Our approach has enabled development of a set of priorities that could inform future research studies and funding decisions. This prioritisation process could also be adapted to other, non-respiratory aspects of long COVID.
影响因子:
15.8
作者:
Fontaine O;Kosek M;Bhatnagar S;Boschi-Pinto C;Chan KY;Duggan C;Martinez H;Ribeiro H;Rollins NC;Salam MA;Santosham M;Snyder JD;Tsai AC;Vargas B;Rudan I
通讯作者:
Rudan I